GSA Capital Partners »

Tarsus Pharmaceuticals shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $209k 5.7k 36.42
2023-12-31 $384k 19k 20.25

More positions owned by GSA Capital Partners

Progressive Corporation (PGR)
Amazon (AMZN)
Root Cl A New (ROOT)
Meta Platforms Cl A (META)
Monster Beverage Corp (MNST)
UGI Corporation (UGI)
Magnite Ord (MGNI)
John B. Sanfilippo & Son (JBSS)
Dt Midstream Common Stock (DTM)
Weis Markets (WMK)
Apa Corporation (APA)
Appfolio Com Cl A (APPF)
Hims & Hers Health Com Cl A (HIMS)
Zoetis Cl A (ZTS)
Vital Farms (VITL)

View all positions for GSA Capital Partners

Top funds holding Tarsus Pharmaceuticals

Cormorant Asset Management
Tang Capital Management
Cowen And Company
Frazier Life Sciences Management
Vanguard Group
Jennison Associates
Perceptive Advisors
Paradigm Biocapital Advisors
Polygon Management
Ikarian Capital
Vivo Capital
Dimensional Fund Advisors
Artisan Partners Limited Partnership
Nantahala Capital Management
Bank of America Corporation

View all funds holding Tarsus Pharmaceuticals